Can bioactive compounds of Crocus sativus L. Influence the metabolic activity of selected CYP enzymes in the rat?

Physiological Research

Volumn 64, Issue , 2015, Pages S453-S458

  Dovrtelova G ^a   Noskova K ^a   Jurica J ^a   Turjap, M ^a,b   Zendulka, O ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL OSTRAVA   (Czech Republic)

Author keywords

Crocin; CYP; Rat liver microsomes; Safranal

Indexed keywords

CAROTENOID; CROCIN; CYCLOHEXENE DERIVATIVE; CYTOCHROME P450; PLANT EXTRACT; SAFRANAL; TERPENE;

ANIMAL; CROCUS; DOSE RESPONSE; DRUG EFFECTS; ENZYME ACTIVATION; ENZYMOLOGY; ISOLATION AND PURIFICATION; LIVER MICROSOME; MALE; METABOLISM; PHYSIOLOGY; RAT; WISTAR RAT;

ANIMALS; CAROTENOIDS; CROCUS; CYCLOHEXENES; CYTOCHROME P-450 ENZYME SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; MALE; MICROSOMES, LIVER; PLANT EXTRACTS; RATS; RATS, WISTAR; TERPENES;

EID: 84983097422     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. AKHONDZADEH S, FALLAH-POUR H, AFKHAM K, JAMSHIDI AH, KHALIGHI-CIGAROUDI F: Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial [ISRCTN45683816]. BMC Complement Altern Med 4: 12, 2004.
2. ALAVIZADEH SH, HOSSEINZADEH H: Bioactivity assessment and toxicity of crocin: a comprehensive review. Food Chem Toxicol 64: 65-80, 2014.
3. BASTI AA, MOSHIRI E, NOORBALA AA, JAMSHIDI AH, ABBASI SH, AKHONDZADEH S: Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: a pilot double-blind randomized trial. Prog Neuropsychopharmacol Biol Psychiatry 31: 439-442, 2007.
4. BATHAIE SZ, MOUSAVI SZ: New applications and mechanisms of action of saffron and its important ingredients. Crit Rev Food Sci Nutr 50: 761-786, 2010.
5. CHOVAN JP, RING SC, YU E, BALDINO JP: Cytochrome P450 probe substrate metabolism kinetics in Sprague Dawley rats. Xenobiotica 37: 459-473, 2007.
6. HADUCH A, WÓJCIKOWSKI J, DANIEL WA: The effect of tricyclic antidepressants, selective serotonin reuptake inhibitors (SSRIs) and newer antidepressant drugs on the activity and level of rat CYP3A. Eur Neuropsychopharmacol 16: 178-186, 2006.
7. HOSSEINZADEH H, NORAEI NB: Anxiolytic and hypnotic effect of Crocus sativus aqueous extract and its constituents, crocin and safranal, in mice. Phytother Res 23: 768-774, 2009.
8. JEWELL C, O'BRIEN NM: Effect of dietary supplementation with carotenoids on xenobiotic metabolizing enzymes in the liver, lung, kidney and small intestine of the rat. Br J Nutr 81: 235-242, 1999.
9. KOBAYASHI K, URASHIMA K, SHIMADA N, CHIBA K: Substrate specificity for rat cytochrome P450 (CYP) isoforms: screening with cDNA-expressed systems of the rat. Biochem Pharmacol 63: 889-896, 2002.
10. KOT M, DANIEL WA: The relative contribution of human cytochrome P450 isoforms to the four caffeine oxidation pathways: an in vitro comparative study with cDNA-expressed P450s including CYP2C isoforms. Biochem Pharmacol 76: 543-551, 2008.
11. LOUISA M, SUYATNA FD, SETIAWATI A, JUSMAN SWA: The effect of lycopene on the total cytochrome P450, CYP1A2 and CYP2E1. Med J Indonesia 18: 233-238, 2009.
12. LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ: Protein measurement with the folin phenol reagent. J Biol Chem 193: 265-275, 1951.
13. MELNYK JP, WANG S, MARCONE MF: Chemical and biological properties of the world's most expensive spice: saffron. Food Res Int 43: 1981-1989, 2010.
14. MICALE V, DI MARZO V, SULCOVA A, WOTJAK CT, DRAGO F Endocannabinoid system and mood disorders: priming a target for new therapies. Pharmacol Ther 138: 18-37, 2013.
15. MOSHIRI E, BASTI AA, NOORBALA AA, JAMSHIDI AH, HESAMEDDIN ABBASI S, AKHONDZADEH S Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebocontrolled trial. Phytomedicine Int J Phytother Phytopharm 13: 607-611, 2006.
16. MOSHIRI M, VAHABZADEH M, HOSSEINZADEH H: Clinical applications of saffron (Crocus sativus) and its sonstituents: a review. Drug Res 65: 287-295, 2015.
17. NOORBALA AA, AKHONDZADEH S, TAHMACEBI-POUR N, JAMSHIDI AH: Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial. J Ethnopharmacol 97: 281-284, 2005.
18. OMURA T, SATO R: The carbon monoxide-binding pigment of liver microsomes I. Evidence for its hemoprotein nature. J Biol Chem 239: 2370-2378, 1964.
19. REZAEE R, HOSSEINZADEH H: Safranal: from an aromatic natural product to a rewarding pharmacological agent. Iran J Basic Med Sci 16: 12-26, 2013.
20. RÍOS JL, RECIO MC, GINER RM, MÁÑEZ S: An update review of saffron and its active constituents. Phytother Res 10: 189-193, 1996.
21. SATOMI Y, NISHINO H: Inhibition of the enzyme activity of cytochrome P450 1A1, 1A2 and 3A4 by fucoxanthin, a marine carotenoid. Oncol Lett 6: 860-864, 2013.
22. SCHMIDT M, BETTI G, HENSEL A: Saffron in phytotherapy: pharmacology and clinical uses. Wien Med Wochenschr 157: 315-319, 2007.
23. SINGLA RK, BHAT VG: Crocin: an overview. Indo Glob J Pharm Sci 4: 281-286, 2011.
24. TARANTILIS PA, TSOUPRAS G, POLISSIOU M: Determination of saffron (Crocus sativus L.) components in crude plant extract using high-performance liquid chromatography-UV-visible photodiode-array detection-mass spectrometry. J Chromatogr A 699: 107-118, 1995.
25. WANG H, LEUNG LK: The carotenoid lycopene differentially regulates phase I and II enzymes in dimethylbenz[a]anthracene-induced MCF-7 cells. Nutrition 26: 1181-1187, 2010.
26. WINTERHALTER P, STRAUBINGER M Saffron - renewed interest in an ancient spice. Food Rev Int 16: 39-59, 2000.
27. WÓJCIKOWSKI J, GOŁEMBIOWSKA K, DANIEL WA: Regulation of liver cytochrome P450 by activation of brain dopaminergic system: physiological and pharmacological implications. Biochem Pharmacol 76: 258-267, 2008.